Ravi Viswanathan

CIK 1479386 · last filed 2022-02-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$19.26B

Companies

28

Total Filings

71

Lifetime Open-Market Net

$112.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DUOL 10%+ Owner 5,239,835 $122.63 $642.56M $0 1 2022-02-16
ESTC 10%+ Owner 1,528,117 $60.35 $92.22M $0 1 2018-10-10
ASND 10%+ Owner 82,978,668 $218.06 $18.09B $49.02M 4 2018-09-10
AVEO PHARMACEUTICALS, INC. (AVEO) Delisted 10%+ Owner 18,698,038 $15.00 $280.47M $8.17M 8 2018-08-22
ARDX 10%+ Owner 3,082,186 $5.69 $17.54M $23.33M 3 2018-05-30
Surface Oncology, Inc. (SURF) Delisted 10%+ Owner 3,312,877 $1.07 $3.54M $2.00M 1 2018-04-23
TESARO, Inc. (TSRO) Delisted 10%+ Owner 9,681,129 $73.31M 6 2018-03-06
Oruka Therapeutics, Inc. (ABIO) Delisted 10%+ Owner 0 $28.80 $0 -$731.3K 1 2018-02-27
Cascadian Therapeutics, Inc. (CASC) Delisted 10%+ Owner 10,882,574 $0 1 2018-02-22
APPN 10%+ Owner 1,523 $24.01 $36.6K -$66.07M 4 2018-02-15
SYBX 10%+ Owner 4,228,940 $0.69 $2.92M $0 2 2018-01-26
Care.com Inc (CRCM) Delisted 10%+ Owner 2,256,013 $0 2 2017-11-08
RYTM 10%+ Owner 4,359,956 $88.38 $385.33M $9.35M 1 2017-10-10
Mersana Therapeutics, Inc. (MRSN) Delisted 10%+ Owner 8,140,138 $29.08 $236.72M $15.00M 1 2017-07-06
MULESOFT, INC (MULE) Delisted 10%+ Owner 0 $0 1 2017-03-22
Achaogen, Inc. (AKAO) Delisted 10%+ Owner 5,215,128 $6.75M 1 2016-12-19
Ra Pharmaceuticals, Inc. (RARX) Delisted 10%+ Owner 3,490,073 $4.39M 1 2016-10-31
Roka BioScience, Inc. (ROKA) Delisted 10%+ Owner 3,216,810 $4.60M 3 2016-09-30
Epizyme, Inc. (EPZM) Delisted 10%+ Owner 406,500 $1.47 $597.6K $23.98M 4 2016-01-12
Avalo Therapeutics, Inc. (CERC.U) Delisted 10%+ Owner 594,245 $0 1 2015-10-20
SYNLOGIC, INC. (MIRN) Delisted 10%+ Owner 1,241,650 $6.00M 1 2015-10-06
BOX 10%+ Owner 0 $25.39 $0 $0 1 2015-01-29
CVENT INC (CVT) Delisted 10%+ Owner 336 $8.52 $2.9K -$46.25M 5 2014-11-28
DERM 10%+ Owner 3,433,810 $6.34 $21.77M $1.11M 1 2014-10-08
Loxo Oncology, Inc. (LOXO) Delisted 10%+ Owner 1,789,420 $3.00M 1 2014-08-06
Clovis Oncology, Inc. (CLVS) Delisted 10%+ Owner 11,399 $0.08 $926 $17.11M 2 2013-06-05
WDAY 10%+ Owner 0 $130.80 $0 $0 2 2013-04-11
Millennial Media Inc. (MM) Delisted 10%+ Owner 8,196,614 -$21.48M 2 2012-10-30

Recent Filings · Page 4 of 8

71 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-22 MULESOFT, INC (MULE) Delisted Mixed −320,780 $0 EDGAR
2016-12-19 Achaogen, Inc. (AKAO) Delisted Buy (P) +500,000 $6.75M EDGAR
2016-11-29 Buy (P) +869,565 $5.00M
2016-10-31 Ra Pharmaceuticals, Inc. (RARX) Delisted Mixed +3,490,073 $4.40M EDGAR
2016-09-30 Roka BioScience, Inc. (ROKA) Delisted Buy (P) $0 EDGAR
2016-09-23 Roka BioScience, Inc. (ROKA) Delisted Buy (P) $0 EDGAR
2016-08-02 Buy (P) +20,120,724 $2.00M
2016-07-20 ARDX Buy (P) +1,527,301 $13.33M EDGAR
2016-03-18 TESARO, Inc. (TSRO) Delisted Buy (P) +1,420,858 $50.00M EDGAR
2016-01-14 ARDX Buy (P) +1,000,000 $10.00M EDGAR
Showing 3140 of 71
Page 4 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.